Allogeneic stem cell transplantation for thalassemia major

Haematologica

Volumn 93, Issue 12, 2008, Pages 1780-1784

  Angelucci, Emanuele ^a   Baronciani, Donatella ^a  

^a Ospedale Oncologico A Businco   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFEROXAMINE; HEMOGLOBIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ALLOGENEIC STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CELL CLONE; CELL TRANSFORMATION; CHELATION THERAPY; CHIMERA; CORD BLOOD STEM CELL TRANSPLANTATION; COST OF ILLNESS; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EDITORIAL; ERYTHROPOIESIS; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HLA MATCHING; HUMAN; IRON OVERLOAD; LIFE EXPECTANCY; ORGAN DONOR; OVERALL SURVIVAL; PATHOPHYSIOLOGY; QUALITY OF LIFE; SICKLE CELL ANEMIA; SURVIVAL RATE; THALASSEMIA MAJOR;

BETA-THALASSEMIA; HEALTH RESOURCES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TRANSPLANTATION, HOMOLOGOUS; WORLD HEALTH;

EID: 57349190679     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.2008.001909     Document Type: Editorial

References (28)

1. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med 2007;357:1472-5.
2. Lucarelli G, Clift R, Angelucci E. Deferoxamine in thalassemia major. N Engl J Med 1995;332:271; author reply 2-3.
3. Schrier SL, Angelucci E. New strategies in the treatment of the thalassemias. Annu Rev Med 2005;56:157-71.
4. Di Bartolomeo P, Santarone S, Di Bartolomeo E, Olioso P, Bavaro P, Papalinetti G, et al. Long-term results of survival in patients with thalassemia major treated with bone marrow transplantation. Am J Hematol 2008;83:528-30.
5. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990;322: 417-21.
6. Lucarelli G, Polchi P, Izzi T, Manna M, Agostinelli F, Delfini C, et al. Allogeneic marrow transplantation for thalassemia. Exp Hematol 1984;12:676-81.
7. Lucarelli G, Polchi P, Galimberti M, Izzi T, Delfini C, Manna M, et al. Marrow transplantation for thalassaemia following busulphan and cyclophosphamide. Lancet 1985; 1:1355-7.
8. Lucarelli G, Galimberti M, Polchi P, Giardini C, Politi P, Baronciani D, et al. Marrow transplantation in patients with advanced thalassemia. N Engl J Med 1987;316:1050-5.
9. Lucarelli G, Weatherall DJ. For debate: bone marrow transplantation for severe thalassaemia (1). The view from Pesaro (2). To be or not to be. Br J Haematol 1991;78:300-3.
10. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Durazzi SM, et al. Bone marrow transplantation in adult thalassemia. Blood 1992;80:1603-7.
11. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 1993;329:840-4.
12. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004;89:1187-93.
13. Angelucci E, Barosi G, Camaschella C, Cappellini MD, Cazzola M, Galanello R, et al. Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Haematologica 2008;93:741-52.
14. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86:480-7.
15. Scalone L, Mantovani LG, Krol M, Rofail D, Ravera S, Bisconte MG, et al. Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study. Curr Med Res Opin 2008;24:1905-17.
16. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008;10:42.
17. Andreani M, Nesci S, Lucarelli G, Tonucci P, Rapa S, Angelucci E, et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant 2000;25:401-4.
18. Lucarelli G, Clift RA, Galimberti M, Angelucci E, Giardini C, Baronciani D, et al. Bone marrow transplantation in adult thalassemic patients. Blood 1999;93:1164-7.
19. Lucarelli G, Clift RA, Galimberti M, Polchi P, Angelucci E, Baronciani D, et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood 1996;87:2082-8.
20. Jacobsohn DA, Duerst R, Tse W, Kletzel M. Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children. Lancet 2004;364: 156-62.
21. Iannone R, Casella JF, Fuchs EJ, Chen AR, Jones RJ, Woolfrey A, et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant 2003; 9:519-28.
22. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003;101:2137-43.
23. Delfini C, Donati M, Marchionni D, Nesci S, Paradisi O, Valentini M, et al. HLA compatibility for patients with thalassemia: implications for bone marrow transplantation. Int J Cell Cloning 1986;4:274-8.
24. Gaziev D, Galimberti M, Lucarelli G, Polchi P, Giardini C, Angelucci E, et al. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants. Bone Marrow Transplant 2000;25:815-21.
25. La Nasa G, Argiolu F, Giardini C, Pession A, Fagioli F, Caocci G, et al. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group. Ann N Y Acad Sci 2005; 1054:186-95.
26. Jaing T-H, Tan P, Rosenthal J, Wang B, Gjertson D, Petz L, Chow R. Unrelated cord blood transplantation (CBT) for thalassemia. Blood (ASH Annual Meeting Abstracts), Nov 2006;108: 554.
27. Lisini D, Zecca M, Giorgiani G, et al. Donor/recipient mixed chimerism does not predict graft failure in children with β-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling. Haematologica 2008;93:1859-67.
28. Lucarelli G, Gaziev J. Advances in the allogeneic transplantation for thalassemia. Blood Rev 2008;22:53-63.